Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial | Zendy

Claudio L. Bassetti | Zendy; F Bornatico | Zendy; Peter Fuhr | Zendy; J Schwander | Zendy; Ulf Kallweit | Zendy; Johannes Mathis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial

Author(s) -

Claudio L. Bassetti,

F Bornatico,

Peter Fuhr,

J Schwander,

Ulf Kallweit,

Johannes Mathis

Publication year - 2011

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2011.13274

Subject(s) - pramipexole , medicine , levodopa , restless legs syndrome , double blind , randomized controlled trial , crossover study , cross over , single blind , physical medicine and rehabilitation , physical therapy , anesthesia , pharmacology , parkinson's disease , placebo , alternative medicine , insomnia , disease , pathology , medical physics

To compare efficacy and safety of the dopamine agonist pramipexole (PPX) versus reference treatment with dual release levodopa/benserazide (L/B) in de novo patients with restless legs syndrome (RLS)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research